Delgocitinib cream 20mg/g significantly improves the sign and symptoms of chronic hand eczema among adolescent patients compared with vehicle cream.

Topical ruxolitinib cream 1.5% for 24 weeks was significantly associated with disease improvement among patients with prurigo nodularis.

Adults with plaque PsO who received continuous icotrokinra had superior efficacy outcomes when compared with those who switched to placebo.

High doses of temtokibart — including 600 mg, 450 mg, and 300 mg — contributed to significant improvements in disease severity in patients with AD.

Levels of systemic inflammatory markers were reduced following 16 weeks of secukinumab treatment in patients with moderate to severe HS.

HealthDay News — The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published online Sept. 3 in JAMA Network ...

Theoretically ending Ryan White services for 5 years was estimated to result in 75,436 additional HIV infections.

The time to onset of action was fastest with IL-17 inhibitors, followed by IL-23, IL-12/23, then PDE-4 and JAK inhibitors for ...

The United States contributed more than half of global public and philanthropic cancer research funding between 2016 and 2023.

The FDA is regulating direct-to-consumer drug advertisements to ensure "fair balance" of information on pharmaceutical products.

An emergency department modified comprehensive geriatric assessment was linked to lower admissions without negative ...

A child in Los Angeles County subacute sclerosing panencephalitis, a complication of measles that affects 1 in 600 infants.